Cyclerion Therapeutics, Inc. (CYCN) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-27 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2026-08-25 | 8-K | Other Events | SEC |
| 2026-04-01 | 8-K | Material Agreement, Change in Control, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-06 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-01 | 8-K | Other Events | SEC |
| 2025-09-23 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-07 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-03-25 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-12-17 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-04-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.